# Pharmaron, Inc.

Canonical: https://abierto.us/vendors/pharmaron-inc-l8nqafstpsy9

- UEI: L8NQAFSTPSY9
- CAGE: 4LFM9
- Location: Waltham, MA
- Awards in window: 11 (12 transactions), $174,267 obligated, March 12, 2024 to September 14, 2026

## Awarding agencies

- National Institutes of Health: 11 awards, $174,267

## Industries

- 541380 Testing Laboratories and Services: $129,727
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $50,300
- 541990 All Other Professional, Scientific, and Technical Services: -$5,760

## Competition

- Not Competed Under SAP: 7 awards
- Competed Under SAP: 4 awards

## Solicitations won

- Mouse PK/PD Study Services for NNMT Inhibitors (75N98026Q00993). https://abierto.us/opportunities/75n98026q00993
- Pharmacokinetic (PK) studies for RXFP1-agonists (75N98026Q00976). https://abierto.us/opportunities/75n98026q00976
- Testing of Compounds for Block of Cardiac Ion Channels (75N95024Q000123), $78,300. https://abierto.us/opportunities/75n95024q000123

## Largest awards

- 75N95024P00164 (purchase order): $78,300, National Institutes of Health Nida. Testing of Compounds in Cardiac Ion Channel Assays. https://www.usaspending.gov/award/CONT_AWD_75N95024P00164_7529_-NONE-_-NONE-/
- 75N98026P01624 (purchase order): $50,300, National Institutes of Health Olao. Ncats: Service: Mouse Pk/Pd Study Services for NNMT Inhibitors: Severable. https://www.usaspending.gov/award/CONT_AWD_75N98026P01624_7529_-NONE-_-NONE-/
- 75N95024P00536 (purchase order): $24,320, National Institutes of Health Nida. Pharmacokinetic Studies of Two Compounds in NON-NAIVE Cynomolgus Monkeys, Using Both Oral and Intravenous Routes of Administration, with Bioanalyses in Plasma Conducted in Triplicate. Pharmaron, INC.:1208250 [24-007191]. https://www.usaspending.gov/award/CONT_AWD_75N95024P00536_7529_-NONE-_-NONE-/
- 75N98026P01622 (purchase order): $19,296, National Institutes of Health Olao. Ncats: Service: Pharmacokinetic (Pk) Studies for Rxfp1-Agonists: Severable. https://www.usaspending.gov/award/CONT_AWD_75N98026P01622_7529_-NONE-_-NONE-/
- 75N95C25P00108 (purchase order): $10,656, National Institutes of Health Ncats. PK Study in Mice. https://www.usaspending.gov/award/CONT_AWD_75N95C25P00108_7529_-NONE-_-NONE-/
- 75N95023P00683 (purchase order): $0, National Institutes of Health Nida. Evaluating Pharmacokinetics of Compounds from Dystonia in Mice, Dogs, Rats. https://www.usaspending.gov/award/CONT_AWD_75N95023P00683_7529_-NONE-_-NONE-/
- 75N95024P00600 (purchase order): $0, National Institutes of Health Nida. Pharmaron, INC.:1208250 [24-007232]. https://www.usaspending.gov/award/CONT_AWD_75N95024P00600_7529_-NONE-_-NONE-/
- 75N95022P00464 (purchase order): -$495, National Institutes of Health Nida. HHS Udo Sprint Exercise - to Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2026, Closing of the Period of Availability of These Fiscal Year Fu. https://www.usaspending.gov/award/CONT_AWD_75N95022P00464_7529_-NONE-_-NONE-/
- 75N95023P00714 (purchase order): -$810, National Institutes of Health Nida. Evaluating Adme of Compounds from Dystonia Project. https://www.usaspending.gov/award/CONT_AWD_75N95023P00714_7529_-NONE-_-NONE-/
- 75N95023P00549 (purchase order): -$1,540, National Institutes of Health Nida. FY26 Udo Initiative. https://www.usaspending.gov/award/CONT_AWD_75N95023P00549_7529_-NONE-_-NONE-/
- 75N95020P00425 (purchase order): -$5,760, National Institutes of Health Nida. To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2020 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2025, Closing of the Period of Availability of These Fiscal Year Funds.. https://www.usaspending.gov/award/CONT_AWD_75N95020P00425_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/pharmaron-inc-l8nqafstpsy9.